Friday, February 10, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
1 of 7
Previous |
Next
Drug Discovery
A New Alternative for High-Throughput Screening
The Accuri C6 Flow Cytometer® System combined with the IntelliCyt™ HyperCyt® Autosampler runs a 384-well plate in ten minutes and provides an affordable flow-based platform for the University of Michigan’s High-Throughput Screening Core.
No Comments
Overcoming Obstacles in Drug Development
Eran Gabbai and Ayelet Dilion Mashiah of Do-Coop Technologies describe a new technology that is turning the tide in the pharmaceutical industry.
No Comments
Streamlining the Drug Discovery Process
Caliper Life Sciences’ Mark Roskey and Bioscan’s Staf C. Van Couter tell us how to reduce R&D costs and increase efficiency.
No Comments
A New Level in Next Generation Sequencing
Peer Staehler of febit holding gmbh tells NGP how the molecular profiling of large patient cohorts is enabled by high-throughput sequencing.
No Comments
Searching for the Holy Grail of Single-Use Solutions
By Barb Paldus, Finesse Solutions, LLC
No Comments
1 of 7
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.